Treatment of fatigue in fibromyalgia

Rheumatic Disease Clinics of North America

Volumn 28, Issue 2, 2002, Pages 367-378

  Guymer, Emma K ^a   Clauw, Daniel J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATIGUE; FIBROMYALGIA; HUMAN; REVIEW; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DRUG EFFICACY; DRUG MEGADOSE; EXERCISE; PATIENT EDUCATION; PRIORITY JOURNAL;

FATIGUE; FIBROMYALGIA; HUMANS; HUMAN;

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; CENTRAL STIMULANT AGENT; CITALOPRAM; CORTICOSTEROID; CYCLOBENZAPRINE; DOPAMINE; FLUDROCORTISONE; FLUOXETINE; HYDROCORTISONE; METHYLPHENIDATE; MOCLOBEMIDE; MODAFINIL; MONOAMINE OXIDASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NORADRENALIN; PHENELZINE; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZOLPIDEM;

EID: 0035990339     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(01)00007-2     Document Type: Review

References (69)

1. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee
2. The prevalence and meaning of fatigue in rheumatic disease
3. Comparison of patients with chronic fatigue syndrome fibromyalgia and multiple chemical sensitivities
4. Fibromyalgia chronic fatigue syndrome and myofascial pain syndrome
5. The concept of affective spectrum disorder: Relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain
6. Deployment stressors and a chronic multisymptom illness among Gulf War veterans
7. Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls
8. Chronic mutlisymptom illness affecting air force veterans of the gulf war
9. Chronic fatigue and the chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system
10. A community-based study of unexplained prolonged and chronic fatiguing illness in a rural area of Michigan
11. Chronic fatigue syndrome: A comprehensive approach to its definition and study
12. Clinical presentation of chronic fatigue syndrome
13. Chronic fatigue syndrome
14. Fatigue: Current bases for practice
15. Fatigue in COPD
16. The measurement of fatigue: A new instrument
17. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue
18. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects
19. Use of a daily journal for fatigue management
20. Defining and measuring fatigue
21. Prescribing exercise for fibromyalgia patients
22. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia
23. A randomized controlled trial of exercise and education for individuals with fibromyalgia
24. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study
25. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome
26. Randomised double-blind placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome
27. Extended outpatient rehabilitation: Its influence on symtom frequency fatigue and functional status for persons with multiple sclerosis
28. Fatigue
29. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy
30. Aerobic exercise: Effects on parameters related to fatigue dyspnoea weight and body composition in HIV-infected adults
31. Biofeedback/relaxation training and exercise interventions for fibromyalgia: A prospective trial
32. Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective randomized study
33. Cognitive-behavioural therapy for somatization and symptom syndromes: A critical review of controlled clinical trials
34. Cognitive behaviour therapy for adults with chronic fatigue syndrome
35. Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial
36. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial
37. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind placebo-controlled trial
38. Randomized controlled trial of CBT to improve functional status in fibromyalgia
39. Antidepressant treatment of fibromyalgia. A meta-analysis and review
40. Antidepressant therapy for unexplained symptoms and symptom syndromes
41. The effect of zolpidem in patients with fibromyalgia: A dose ranging double blind placebo controlled modified crossover study
42. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia
43. A double-blind placebo controlled trial of fluoxetine in fibromyalgia
44. A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
45. A randomized controlled trial of citalopram in the treatment of fibromyalgia
46. Randomized double-blind placebo-controlled study of fluoxetine in chronic fatigue syndrome
47. Randomized double blind controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome
48. A randomized double-blind placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder
49. A randomized double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome
50. An open clinical trial of venlafaxine treatment of fibromyalgia
51. Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study
52. Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours
53. Randomized double-blind placebo-controlled crossover trial of modafinil in the treatment of excessive day-time sleepiness in narcolepsy
54. Modafinil: The unique properties of a new stimulant
55. Self-monitoring cognitive performance during sleep deprivation: Effects of modafinil d-amphetamine and placebo
56. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome
57. Oral treatment of fibromyalgia with tropisetron given over 28 days: Influence on functional and vegetative symptoms psychometric parameters and pain
58. Treatment of fibromyalgia with tropisetron a 5HT3 serotonin antagonist: A pilot study
59. Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - Preliminary results
60. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial
61. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial
62. The relationship between neurally mediated hypotension and the chronic fatigue syndrome
63. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial
64. Treatments for fatigue in multiple sclerosis: A rapid and systematic review
65. A double-blind placebo-controlled trial of amantadine in the treatment of fatigue in patients with the post-polio syndrome
66. Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation
67. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome
68. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome
69. Effect of gamma-hydroxybutyrate on pain fatigue and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report